OSMA's EMR Standards of Excellence Program Eases EMR Adopti... ( Program Enters its Second Year with N...)

OSMA's EMR Standards of Excellence Program Eases EMR Adoption Process

Date:3/3/2009

Program Enters its Second Year with New Vendors for 2009

COLUMBUS, Ohio, March 3 /PRNewswire/ -- State and federal lawmakers are calling for an expansion of health information technology (HIT) use by physicians and hospitals by making funding available. Ohio's executive budget has provisions for an increase in HIT funds and the recently passed federal economic stimulus package contains $19 billion in Medicare and Medicaid HIT incentives including for the adoption of electronic medical record systems (EMR). While the details for obtaining these funds are yet to be determined, the Ohio State Medical Association (OSMA) is offering physicians a chance to get a head start on the process of adopting EMR through the OSMA's EMR Standards of Excellence Program (EMR SOE).

"We are happy that lawmakers are making the expansion of health information technology a priority, especially in these difficult economic times," said OSMA President Warren F. Muth, MD. "The OSMA's EMR SOE Program gives our member practices the tools to succeed in selecting an EMR vendor during the multi-step and sometimes confusing selection and adoption process."

The EMR SOE Program began in March of last year and is available exclusively to OSMA members. The innovative program helps reduce the risk for physicians who wish to adopt an EMR by identifying vendors who have agreed to include physician-friendly terms and conditions in their contracts with medical practices. In addition, at a minimum, the EMR vendors in the program must be certified by the Certification Commission for Healthcare Information Technology (CCHIT).

The typical EMR vendor selection process can take as long as two years as a medical practice has to research and sort through hundreds of different vendors. OSMA members say that by identifying physician-friendly vendors, the EMR SOE Program has helped save them time and money as well as lower the risk associated wi
'/>"/>

SOURCE Ohio State Medical Association
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Environmental Defense Fund Welcomes EPA Clean Air Standards to Reduce Hazardous Diesel Pollution
2. Osteotech Receives 13485:2003 ISO Certification; Company Meets International Standards for Medical Device Manufacturing
3. China Shenghuo Receives Notice from NYSE Alternext US Regarding Listing Standards
4. RediClinic Meets Strict Quality and Safety Standards for Retail Clinics
5. URAC Calls for Public Comment on Revisions to its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM), Version 2.0 Standards and NEW Performance Measures, and PHARM Core, Version 3.0 Standards
6. Leading UK Personal Trainer Challenges Standards of Service Within Fitness Industry to Get Results or Double Your Money Back Guarantee
7. American Association for Homecare Proposes to Congress a Medicare Anti-Fraud Action Plan that Includes Increased Penalties, Site Inspection, and Tough Standards
8. USP announces new standards to protect patients from counterfeit and adulterated medicines
9. New Standards Set for Heparin and Glycerin
10. HHS Secretary Recognizes Products of HITSP Standards Work
11. CNA/NNOC Criticizes SEIU Trusteeship: Cites Concerns for Erosion of RN and Patient Care Standards

Post Your Comments:

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... of Autoimmune Diseases Therapeutics - Market ... Pipeline and Deals Analysis ... Summary ,, The author has ...

(Date:12/15/2009)... ALPHARETTA, Ga., Dec. 15 Hosted by ... the 4th annual event recognized 2009,s best eLearning ... all, were spread across 4 categories. The ... developed for the world,s largest hotelier, was selected ... Hours of Custom eLearning" category by the panel ...

(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...

(Date:12/15/2009)... is being released by the American Health Information Management ... RHIT, CCS, FAHIMA ,, AHIMA President ... ,, On behalf of the A-H-I-M-A Board of Directors...it ... executive officer, Doctor Alan Dowling... ,, Back last summer ... who we knew could effectively replace Linda ...

[0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST

... more than 60 orders for faster form of image-guided ... intensity-modulated radiation therapy, PALO ... ) today announced it has received more than 60 orders ... RapidArc orders have been,concentrated in North America but have also ...

... The NCCA accredited the National,Exercise & ... a five-year period, expiring March 31, 2013, ... NESTA is a professional certification organization,acting in ... education,examination, experience and ethics requirements for certification., ...

... Association urges Senators Cardin and Mikulski to quickly pass,companion ... 23 AARP thanked the,supporters and cosponsors of the ... today in the U.S. House of Representatives. The bill,prevents ... stopping,harmful cuts proposed by the administration., "Today,s vote ...

... Expert says goal is to maintain strength, not gain it, ... If you,re an athlete or fitness enthusiast who suffers a ... have to stop exercising. , , "Exercise can definitely be ... its type, the injured area should be moved and not ...

... and Tour Groups, CHICAGO, April 23 ... Bank of America Chicago Marathon has closed as ... race, marking the event,s,established capacity. A limited number ... tour groups., (Logo: http://www.newscom.com/cgi-bin/prnh/20050720/CLW086LOGO-b ), ...

... with these headaches suffer from skin discomfort, study finds, ... have migraines -- either chronic or episodic -- are ... sensitivity, new research shows. , As many as two-thirds ... condition called cutaneous allodynia. Cutaneous allodynia is skin sensitivity ...

Other Medicine News:Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 2 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 3 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 4 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 5 Health News:The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA) 2 Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2 Health News:Exercise Plays Role in Recovery From Sports Injuries 2 Health News:2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity 2 Health News:Skin Pain, Sensitivity Rises With Migraine 2 Health News:Skin Pain, Sensitivity Rises With Migraine 3

Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA)AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid Exercise Plays Role in Recovery From Sports Injuries 2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity Skin Pain, Sensitivity Rises With Migraine

(Date:12/15/2009)... -- Masimo (Nasdaq: MASI ), the inventor ... Perfusion pulse oximetry, today announced that Masimo Chairman ... 2009 Frost & Sullivan CEO of the Year ... According to Frost & Sullivan, the award is ... in understanding customer requirements, developing new technologies, delivering ...

(Date:12/15/2009)... MALVERN, Pa. and WALTHAM, Mass., Dec. 15 /PRNewswire/ ... find that methicillin-resistant Staphylococcus aureus (MRSA) ... infectious disease specialists with regard to their treatment ... activity against MRSA is among the top factors ... skin and skin structure infections. Other key factors ...

(Date:12/15/2009)... -- Bend Research Inc. announced,today that its clients may ... used in technologies developed by the firm to enhance ... Bend Research clients may now reference a ... filings with the FDA, Bend Research officials said. , ... development and know it will assist our,clients in accelerating ...

Breaking Medicine Technology:Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3 Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2 An atomic level look at an HIV accomplice 61728 1 An atomic level look at an HIV accomplice 61728 2 Bioreactor for bone tissue engineering wins professor venture fair 10813 1 Bioreactor for bone tissue engineering wins professor venture fair 10813 2 Bioreactor for bone tissue engineering wins professor venture fair 10813 3 Drug studied as possible treatment for spinal injuries 10811 1 Drug studied as possible treatment for spinal injuries 10811 2 Drug studied as possible treatment for spinal injuries 10811 3

[0] Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award [0] A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections [0] Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient

... in Repeat-Dosing Study in Subjects with ALS, RICHMOND, ... ) announced today that it has opened a Phase,2 ... subjects,with ALS, a progressive, degenerative motor-neuron disease for which ... drug, SB-509, is an injectable formulation of a plasmid,encoding ...

... Sept. 3 Forest Laboratories, Inc.,(NYSE: ... announced results from,two global Phase III studies ... for the treatment of patients with chronic,obstructive ... I&II,(AClidinium CLinical Trial Assessing Efficacy and Safety ...

Other Medicine Technology:Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Allergen, Weed, Kochia/Firebush Allergen, Tree, Willow Tree Allergen, Tree, White Ash Tree Allergen, Tree, White Pine Tree

OSMA's EMR Standards of Excellence Program Eases EMR Adopti...( Program Enters its Second Year with N...),Health